The legacy success of sildenafil has undeniably influenced the drug landscape. However, investing in companies heavily focused on biosimilars and the diminishing patent rights surrounding this blockbuster https://icelisting.com/story22649518/the-blue-pill-and-pharmaceutical-companies-a-risky-venture